Telavancin: a novel lipoglycopeptide for serious Gram-positive infections

Author: Laohavaleeson Somvadee   Kuti Joseph L   Nicolau David P  

Publisher: Informa Healthcare

ISSN: 1354-3784

Source: Expert Opinion on Investigational Drugs, Vol.16, Iss.3, 2007-03, pp. : 347-357

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract